Neuromuscular Disorders
Volume 22, Issue 1 , Pages 13-15, January 2012

Amyloidosis and exercise intolerance in ANO5 muscular dystrophy

  • Margherita Milone

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Tel.: +1 507 538 1037.
  • ,
  • Teerin Liewluck

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN, USA
  • ,
  • Thomas L. Winder

      Affiliations

    • PreventionGenetics, Marshfield, WI, USA
  • ,
  • Paolo T. Pianosi

      Affiliations

    • Department of Pediatrics, Mayo Clinic, Rochester, MN, USA

Received 10 May 2011; received in revised form 1 July 2011; accepted 8 July 2011. published online 22 September 2011.

Abstract 

Anoctamin 5 and dysferlin mutations can result in myopathies with similar clinical phenotype. Amyloid deposits can occur in the muscle of patients with dysferlinopathy. We describe a 53-year-old woman with exercise intolerance since childhood, recurrent rhabdomyolysis and late-onset weakness. Muscle biopsy showed amyloid deposits within the blood vessel walls and around muscle fibers. Mutation analysis identified two pathogenic heterozygous mutations in anoctamin 5 and no mutations in dysferlin. To our knowledge this is the first report of muscle amyloidosis in anoctamin 5 muscular dystrophy. This finding suggests that patients with amyloid in muscle should be screened for anoctamin 5 muscular dystrophy.

Keywords: ANO5, Amyloidosis, Muscular dystrophy, Anoctaminopathy, Anoctamin 5

 

PII: S0960-8966(11)01309-5

doi:10.1016/j.nmd.2011.07.005

Neuromuscular Disorders
Volume 22, Issue 1 , Pages 13-15, January 2012